Search Results - "Askin, Scott"

Common data elements for secondary use of electronic health record data for clinical trial execution and serious adverse event reporting by Bruland, Philipp, McGilchrist, Mark, Zapletal, Eric, Acosta, Dionisio, Proeve, Johann, Askin, Scott, Ganslandt, Thomas, Doods, Justin, Dugas, Martin

“…Data capture is one of the most expensive phases during the conduct of a clinical trial and the increasing use of electronic health records (EHR) offers…”
Get full text

Evolving regulatory perspectives on digital health technologies for medicinal product development by Colloud, Seya, Metcalfe, Thomas, Askin, Scott, Belachew, Shibeshih, Ammann, Johannes, Bos, Ernst, Kilchenmann, Timothy, Strijbos, Paul, Eggenspieler, Damien, Servais, Laurent, Garay, Chloé, Konstantakopoulos, Athanasios, Ritzhaupt, Armin, Vetter, Thorsten, Vincenzi, Claudia, Cerreta, Francesca

“…Digital health technology tools (DHTTs) present real opportunities for accelerating innovation, improving patient care, reducing clinical trial duration and…”
Get full text

Artificial Intelligence Applied to clinical trials: opportunities and challenges by Askin, Scott, Burkhalter, Denis, Calado, Gilda, El Dakrouni, Samar

“…Background Clinical Trials (CTs) remain the foundation of safe and effective drug development. Given the evolving data-driven and personalized medicine…”
Get full text

Digital technologies for medicines: shaping a framework for success by Cerreta, Francesca, Ritzhaupt, Armin, Metcalfe, Thomas, Askin, Scott, Duarte, João, Berntgen, Michael, Vamvakas, Spiros

“…Regulatory agencies can provide advice to support developers of digital technologies for medicines use, but what are the best strategies to maximize the chance…”
Get full text

Opportunities and Challenges for Decentralized Clinical Trials: European Regulators’ Perspective by Jong, Amos J., Rijssel, Tessa I., Zuidgeest, Mira G. P., Thiel, Ghislaine J. M. W., Askin, Scott, Fons‐Martínez, Jaime, De Smedt, Tim, Boer, Anthonius, Santa‐Ana‐Tellez, Yared, Gardarsdottir, Helga

“…Decentralized clinical trials (DCTs) have the potential to improve accessibility, diversity, and retention in clinical trials by moving trial activities to…”
Get full text